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Abstract: Protein Energy Wasting (PEW) in hemodialysis (HD) patients is a multifactorial condition 
due to specific pathology-related pathogenetic mechanisms, leading to loss of skeletal muscle mass 
in HD patients. Computed Tomography and Magnetic Resonance Imaging still represent the gold 
standard techniques for body composition assessment. However, their widespread application in 
clinical practice is difficult and body composition evaluation in HD patients is mainly based on 
conventional anthropometric nutritional indexes and bioelectrical impedance vector analysis 
(BIVA). Little data is currently available on ultrasound (US)-based measurements of muscle mass 
and fat tissue in this clinical setting. The purpose of our study is to ascertain: (1) if there are 
differences between quadriceps rectus femoris muscle (QRFM) thickness and abdominal/thigh 
subcutaneous fat tissue (SFT) measured by US between HD patients and healthy subjects; (2) if there 
is any correlation between QRFM and abdominal/thigh SFT thickness by US, and 
BIVA/conventional nutritional indexes in HD patients. We enrolled 65 consecutive HD patients and 
33 healthy subjects. Demographic and laboratory were collected. The malnutrition inflammation 
score (MIS) was calculated. Using B-mode US system, the QRFM and SFT thicknesses were 
measured at the level of three landmarks in both thighs (superior anterior iliac spine, upper pole of 
the patella, the midpoint of the tract included between the previous points). SFT was also measured 
at the level of the periumbilical point. The mono frequency (50 KHz) BIVA was conducted using 
bioelectrical measurements (Rz, resistance; Xc, reactance; adjusted for height, Rz/H and Xc/H; PA, 
phase angle). 58.5% were men and the mean age was 69 (SD 13.7) years. QRFM and thigh SFT 
thicknesses were reduced in HD patients as compared to healthy subjects (p < 0.01). Similarly, also 
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BIVA parameters, expression of lean body mass, were lower (p < 0.001), except for Rz and Rz/H in 
HD patients. The average QRFM thickness of both thighs at top, mid, lower landmarks were 
positively correlated with PA and body cell mass (BCM) by BIVA, while negatively correlated with 
Rz/H (p < 0.05). Abdominal SFT was positively correlated with PA, BCM and basal metabolic rate 
(BMR) (p < 0.05). Our study shows that ultrasound QRFM and thigh SFT thicknesses were reduced 
in HD patients and that muscle ultrasound measurements were significantly correlated with BIVA 
parameters.  
Keywords: BIVA; fat tissue; muscle mass; PEW; ultrasonography 
 
1. Introduction 
Protein energy wasting (PEW) is a condition peculiar to the most advanced stages of chronic 
kidney disease (CKD), and especially hemodialysis (HD) patients [1,2], and is associated with 
increased morbidity and mortality [3–5]. PEW is characterized by inadequate intake of nutrients, loss 
of energy reserves, derangements in body composition, and increased muscle protein catabolism, 
leading to lean body mass loss [6,7]. According to the International Society of Renal Nutrition and 
Metabolism (ISRNM) [8], reduced total body fat and muscle mass are relevant indicators for the 
diagnosis of PEW.  
Currently, Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) are the gold 
standard for the assessment of body composition [9], but they are expensive, not practical nor always 
available in clinical practice, technically complex and, at least in the case of CT, it exposes patients to 
excess radiation [10].  
Other methods such as dual-energy X-ray absorptiometry (DEXA) and bio-impedance analysis 
(BIA) have been used to assess body composition [11]. However, these methods can be inaccurate 
since they can be confounded by fluid status [12]. Other nutritional parameters, such as 
anthropometry and biochemical analysis are considered surrogates of muscle and fat mass; however, 
they do not provide enough information to allow for an accurate assessment of body composition 
status, because of the high variability of fluid status in HD patients and the presence of inflammation 
[13]. 
Considering all the limitations and pitfalls of the available tools for the assessment of body 
composition, the application of ultrasound technique to skeletal muscle could represent an 
interesting alternative tool and gained considerable interest in the last few years [14]. In critically ill 
patients, quadriceps femoris muscle mass is a very important parameter of muscularity, and its 
quantification is an indicator of lean body mass status and is not influenced by rapid fluid shifts 
[15,16]. In HD patients, quadriceps US was able to identify patients with worse nutritional status [17]. 
Moreover, the reliability and validity of the method as an alternative tool for the assessment of muscle 
mass was recently demonstrated also in patients with acute kidney injury [15,18]. Similarly, 
abdominal ultrasound for the assessment of visceral fat and quadriceps ultrasound for the assessment 
of subcutaneous fat also resulted reliable compared to DEXA, the reference technique, in medical 
settings [19–21]. 
The present study was aimed at investigating: (a) whether any difference exists in quadriceps 
rectus femoris muscle (QRFM) thickness and the abdominal/thigh subcutaneous fat tissue (SFT) 
thickness measured by US between HD patients and healthy subjects; (b) whether any correlation 
exist between QRFM, abdominal and thigh SFT, on one hand and bioelectrical impedance vector 
analysis (BIVA) parameters and conventional anthropometric and biochemical indexes of nutritional 
status in HD patients on the other hand. 
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2. Materials and Methods 
A cross-sectional, observational, single center study was performed at the Hemodialysis Center 
of the Ferrara University Hospital. The study was approved by the Local Institutional Review Board 
(Ref No. 170192, 13 April 2017). The procedures were in agreement with the Declaration of Helsinki 
and written informed consent was obtained from all the participants. 
2.1. Patients 
Ninety-eight consecutive patients receiving chronic HD treatment were evaluated from June 
2017 to December 2018. Exclusion criteria were limb amputation; prolonged hospitalization within 
the previous 30 days; bedridden or immobilization syndrome; dialysis vintage less than six months; 
presence of cardiac pacemaker, implantable cardioverter-defibrillator, or metallic non-removable 
pieces.  
Thirty-three healthy subjects from the hospital staff were enrolled. Inclusion criteria were age 
>18 years and absence of chronic or acute diseases. 
In HD patients, demographic, clinical and anthropometric data were collected, and routine 
biochemistry was measured at the time of US and BIVA measurement. Daugirdas’ formula was used 
for standard Kt/V urea calculation, a DOQI-approved method [22]. Body mass index (BMI) was 
calculated as weight (kg)/height2 (m2). 
2.2. Ultrasound Technique 
QRFM thickness was measured using B-mode US system (Philips Envisor C HD) and 7.5 MHz 
linear array transducer, by an expert nephrologist at the patients’ bedside. The transducer was placed 
perpendicular to the long axis of the thigh, with minimal pressure to avoid compression of the 
muscle. Patients were laid down in a supine position with both knees extended but relaxed and toes 
pointing upwards, with legs forming a 45 °C angle. 
QRFM thickness was measured in both thighs as the distance between the inferior surface of the 
fascia and the superior surface of the vastus femoris muscle. Measurements were performed at the 
level of three landmarks: the superior anterior iliac spine (top); the upper pole of the patella (lower); 
the midpoint of the tract included between the previous points (mid).  
The thickness of the peripheral SFT was measured at the same three landmarks of the both thighs 
while abdominal SFT was measured at the level of the xiphopubic line above the umbilicus, 
calculating the distance between the inferior surface of the derma and the superior surface of the most 
superficial muscular fascia. The measurement was repeated two times and the average value was 
used in the analyses. Assessor performed a total of 26 measurements (12 for QRFM and 14 for SFT) 
in each subject.  
2.3. Body Composition Evaluation 
The monofrequency (50 KHz) BIVA (AKERN EFG Plus®, Pontassieve, FI, USA, with hydrasite 
technology) was used to obtain Rz, resistance; Xc, reactance; adjusted for height, Rz/H and Xc/H; and 
PA, phase angle) [23]. Body cell mass (BCM), extra-cellular mass (ECW), basal metabolic rate (BMR) 
were estimated from BIVA parameters [24].  
Two electrodes, placed at a distance >5 cm, were attached to the same side arm and leg and to 
the opposite side of the arteriovenous fistula in supine patients. Measurements were performed 20 
min after the end of the mid-week dialysis session [25]. Patients were instructed to take their meals 2 
h before dialysis to avoid interference effects of the meal and were not allowed to eat during the 
course of dialysis. 
HD patients were independently evaluated for PEW diagnosis by a different assessor blinded to 
US measurements; the ISRNM criteria for PEW were used. Briefly, according to ISRNM panel, three 
out of the four categories, namely serum chemistry; body mass; muscle mass; and dietary intake, 
must be satisfied for the diagnosis of kidney disease-related PEW [26].  
Nutrients 2020, 12, 1388 4 of 14 
 
Malnutrition inflammation score (MIS) questionnaire was used to assess the degree of malnutrition 
and inflammation of patients on HD. MIS has four sections including nutritional history, physical 
examination, BMI and laboratory values; each section receives a score between 0 (normal) to 3 
(severely malnourished). Higher scores mean a more severe degree of malnutrition and inflammation 
[27].  
2.4. Statistical Analysis 
Statistical analysis was performed with SPSS (version 23, IBM Corp. Armonk, NY, USA). Data 
were expressed as means and standard deviations or median and interquartile range (IQR) based on 
their distribution for continuous variables; and as frequencies (percentage) for categorical variables. 
ANOVA was used to compare the laboratory differences among three subgroups (MIS score, BMI, 
and albumin) of HD patients. Differences in muscle and fat thickness between HD patients and 
controls were adjusted for age, gender, and BMI. The correlation between BIVA parameters and 
muscle/fat thickness was assessed by Pearson’s correlation coefficient for parametric data and 
Spearman correlation coefficient for non-parametric data. A multivariable approach was used to 
assess the association between both the BIVA parameters and QRFM/SFT thicknesses ultrasound, 
and nutritional indexes (MIS score, BMI, and albumin) of HD patients. Firstly, we tested univariate 
associations between the MIS score, BMI, and albumin, modeled as continuous variables, and 
alternatively BIVA or QRFM/SFT parameters by means of linear regression analysis. The variables 
with p < 0.15 at univariate analysis were selected and included in the first multivariate regression 
model. Next, backward variable selection method with an elimination criterion of p < 0.10 was 
performed to fit the second multivariate linear regression model.  
3. Results 
Ninety-eight HD patients were screened for enrollment, and 65 patients were enrolled in the 
study; three patients were excluded for amputation of arts, five patients for prolonged hospitalization 
within the previous 30 days, seven patients for being bedridden or with immobilization syndrome, 
nine patients for dialysis vintage less than six months, three patients for presence of cardiac 
pacemaker, two patients for implantable cardioverter-defibrillator, four patients for denial of consent.  
Thirty-three healthy subjects were also enrolled; HD patients were older than healthy subjects 
(69 [SD 13.7] vs. 47.2 [SD 7.5] years; p < 0.001). No statistically significant differences were found 
between two groups in the anthropometric parameters (weight: 68 [SD 16.9] vs. 62.4 [SD 12.3] kg, p = 
0.067; height:165.7 [SD 10.4] vs. 164.9 [SD 6.1] cm, p = 0.07; BMI: 24.6 [SD 4.9] vs. 22.9 [SD 3.7] kg/m2, 
p = 0.058).  
Demographic, clinical, and nutritional data of HD patients are shown in Table 1. Thirty-eight 
out of 65 (58.5%) were males, the mean weight loss in the last 6 months was 1.1 Kg (SD 4.1), and 
serum albumin was 3.7 g/dL (SD 0.4). 
HD patients were stratified according to three common nutritional indexes (MIS score, BMI, and 
albumin) (supplementary Table S1). In summary, albuminemia and TIBC were significantly different 
between MIS score subgroups (MIS score >6 vs. MIS score <6) (p < 0.01). Kt/v was different between 
the albumin subgroups (albumin >3.8 g/dL vs. albumin <3.8 g/dL) (p < 0.001). The differences in MIS 
score between BMI subgroups (BMI >23 kg/m2 vs. BMI <23 kg/m2) was not statistically significant (p 
= 0.06). No differences in age and inflammatory status, as assessed by CRP, were found between 
subgroups.  
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Table 1. Demographic, and clinical data of hemodialysis patients. 
Socio-Demographic Variables Clinical Variables 
Age, years * 69 (13.7) Systolic Blood Pressure, mm hg * 138.3 (22.8) 
Sex, Males, n (%) 38 (58.5) Diastolic Blood Pressure, mm hg * 73.4 (11.8) 
Weight loss, last 6 months ** −1.0 (−2.5–0.45) Heart Rate, bpm * 68.4 (9.4) 
  Height, cm * 165.7 (10.4) 
Diabetes mellitus, % 29.2 Weight, kg * 68 (16.9) 
Caucasian race, % 98.5 Body Mass Index, kg/m2 * 24.6 (4.9) 
Diabetes mellitus, % 29.2   
Previous Stroke, % 20 Blood Test Values  
COPD, % 18.5 Serum phosphorus, mg/dL * 6.1 (2.5) 
Cardiovascular diseases, % 36.9 Serum calcium, mg/dL * 9.3 (0.8) 
PAD, % 30.8 PTH, pg/mL ** 217 (116.5–377) 
Previous renal transplantation, % 9.2 Albumin, g/dL * 3.7 (0.4) 
History of cancer, % 30.8 Ferritin, microg/L ** 285 (80.5–491.5) 
  Transferrin, mg/dL * 188.4 (43.5) 
Kidney disease:  Serum iron, microg/dL * 57.8 (29.3) 
Glomerulonephritis, % 20 Total Iron Binding Capacity, mg/dL * 235.5 (54.3) 
Nephroangiosclerosis, % 16.9 Total Cholesterol, mg/dL * 161.3 (47.4) 
ADPKD, % 4.6 HDL Cholesterol, mg/dL * 39.9 (11.2) 
Others, % 26.2 Triglycerides, mg/dL ** 140 (103–197) 
  C-reactive Protein, mg/dL ** 0.46 (0.19–0.85) 
  KT/V 1.4 (0.3) 
* Data are expressed as means (standard deviations); ** Data are expressed as median and range 
Interquartile; ADPKD: Autosomal dominant polycystic kidney disease; COPD: chronic obstructive 
pulmonary disease; HDL: high-density lipoprotein; PAD: peripheral artery disease; PTH: 
parathormone.  
Ultrasound thickness of QRFM and SFT were significantly lower at all of the explored sites 
compared to the control group, except for the abdominal SFT (2.61 [SD 1.2] vs. 2.67 [SD 1.12], p = 0.79) 
(Figures 1 and 2).  
 
Figure 1. Quadriceps rectus femoris thickness of hemodialysis patients and healthy subjects; ∞ 
significance = p < 0.01; QRFT: Quadriceps rectus femoris thickness; LT: left thigh; RT: right thigh. 
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Figure 2. Abdominal/thigh subcutaneous fat thickness of hemodialysis patients and heathy subjects; 
∞ significance = p < 0.01; SFT: subcutaneous fat tissue; LT: left thigh; RT: right thigh. 
At the multivariate linear regression analysis, after backward selection of variables, with an 
elimination criterion of p < 0.10, abdominal SF and Lower QRFM thickness were significantly 
associated with BMI, Mid-Thigh SFT thickness was associated with Albumin, whereas Top QRFM 
thickness was found to predict MIS score β coefficients with 95% confidence intervals are depicted in 
Table 2. Also, a significant correlation between two nutritional indexes (MIS score and albumin) and 
some BIVA parameters was found (p < 0.05) (Supplementary Table S2). 
Table 2. Correlation between SFT / QRTM thickness and nutritional indexes (BMI, albumin, MIS 
score) in hemodialysis patients. 




95 % CI 
B St. Error Beta LB UB 
(Constant) 13.369 2.448 . 5.461 0.000 8.470 18.267 
Abdominal SFT 
thickness 
1.341 0.507 0.323 2.646 0.010 0.327 2.356 
Lower QRFM 
thickness 
10.173 3.067 0.350 3.317 0.002 4.036 16.310 




95 % CI 
B St. Error Beta LB UB 
(Constant) 18.141 2.713   6.688 0.000 12.713 23.569 
Mid Thigh SFT 
thickness 
3.381 1.841 .343 1.837 0.071 −0.303 7.064 
Lower Thigh SFT 
thickness 
−3.584 2.004 −.339 −1.788 0.079 −7.594 0.427 
Top QRFM 
thickness 
−4.432 1.320 −0.377 −3.358 0.001 −7.073 −1.791 
Lower QRFM 
thickness 
−6.007 3.221 −.208 −1.865 0.067 −12.453 0.439 




95 % CI 
B St. Error Beta LB UB 
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(Constant) 3.480 .224   15.506 0.000 3.031 3.929 
Mid Thigh SFT 
thickness 
−0.489 0.152 −0.622 −3.211 0.002 −0.794 −0.184 
Top QRFM 
thickness 
0.195 0.109 0.208 1.789 0.079 −0.023 0.414 
BMI: Body Mass Index; CI: Confidence Interval; LB: Lower Bound; LT: Left Thigh; MIS: Malnutrition 
Inflammation Score; PA: Phase Angles; QRFM: Quadriceps Rectus Femoris Muscle; RT: Right Thigh; 
SC: Standardized Coefficients; SFT: Subcutaneous Fat Tissue; UB: Upper Bound; UC: Unstandardized 
Coefficients. 
BIVA parameters were significantly reduced in HD patients compared with healthy subjects (p 
< 0.01), except for Rz and Rz/H. Conversely, extracellular water (ECW) increased (p < 0.005) (Table 3).  
Table 3. Bioelectrical impedance analysis parameters of hemodialysis patients and heathy subjects. 
 Patients (n = 65) Controls (n = 33) p 
Rz 545.7 (82.9) 569.5 (69.6) 0.63 
Xc 42.8 (11.3) 60.3 (9.3) 0.001 
Rz/H 3.3 (0.58) 3.5 (0.5) 0.46 
Xc/H 0.26 (0.07) 0.4 (0.07) 0.003 
BCM 19.8 (8.3) 24.4 (5.9) <0.001 
BMR KJOULE 5362.9 (1262.9) 6203.5 (522.7) 0.007 
BMR KCAL 1262.5 (340.1) 1482.7 (124.9) <0.01 
ECW 29.2 (15.9) 15.3 (3.3) 0.005 
PHASE ANGLE 4.5 (1.2) 6.1 (0.8) <0.001 
Data are expressed as means (standard deviations); BCM: Body cell mass; BMR: basic metabolic rate; 
ECW: extra-cellular mass; H: height; Rz: resistance; Xc: reactance. 
The average QRFM thickness of both thigh at top, mid, and lower landmarks were negatively 
correlated with Rz/H and positively with PA and BCM (p < 0.05), whereas the abdominal SFT 
thickness was significantly and positively correlated with PA, BCM and BMR (Tables 4 and 5) 
(supplementary Figures S1 and S2). 
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Table 4. Correlation between quadriceps rectus femoris thickness and BIVA parameters in hemodialysis patients. 
  RZ RZ/H XC XC/H BCM BMR KJOULE PHASE ANGLE 
TOP QRFM THICKNESS (P−VALUE) −0.236(0.058) −0.319 (0.010) * 0.125 (0.322) 0.055 (0.661) 0.12 (0.011) * 0.355 (0.004) * 0.315 (0.011) * 
MID QRFM THICKNESS (P−VALUE)  −0.257 (0.039) * −0.264(0.034) * 0.11 (0.383) 0.093 (0.461) 0.258 (0.038) * 0.294 (0.018) * 0.232 (0.043) * 
LOWER QRFM THICKNESS (P−VALUE) −0.239 (0.057) −0.273 (0.029) * −0.280 (0.025) 0.212 (0.092) 0.365 (0.003) * 0.128 (0.312) 0.423 (<0.001) * 
* significance = p < 0.05; BCM: Body cell mass; BMR: basic metabolic rate; H: height; QRFM: quadriceps rectus femoris; Rz: resistance; Xc: reactance. 
Table 5. Correlation between abdominal/thigh subcutaneous fat thickness and BIVA parameters in hemodialysis patients. 
 Rz Rz/H Xc Xc/H BCM BMR KJOULE PHASE ANGLE 
Abdominal SFT thickness 
(p−value) 
−0.148 (0.239) −0.204 (0.102) 0.218 (0.081) 0.161 (0.200) 0.294 (0.018) * 0.303 (0.014) * 0.299 (0.016) * 
Top Thigh SFT thickness 
(p−value) 
−0.27 (0.83) 0.036 (0.778) −0.001 (0.992) 0.033 (0.793) 0.013 (0.919) −0.041 (0.746) −0.034 (0.785) 
Mid Thigh SFT thickness 
(p−value) 
0.014 (0.91) 0.161 (0.2) −0.055 (0.661) 0.043 (0.732) −0.211 (0.092) −0.119 (0.346) −0.087 (0.493) 
Lower Thigh SFT thickness 
(p−value) 
−0.088 (0.487) −0.018 (0.886) 0.068 (0.588) 0.212 (0.089) 0.066 (0.601) 0.160 (0.204) 0.225 (0.071) 
* significance = p < 0.05; BCM: Body cell mass; BMR: basic metabolic rate; H: height; Rz: resistance; SFT: subcutaneous fat tissue; Xc: reactance. 
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4. Discussion and Conclusion  
In this study, we showed that QRFM and thigh SFT thicknesses of HD patients, evaluated by the 
ultrasound technique, were reduced in comparison to healthy subjects and that QRFM thickness was 
associated with PA, one of the most reliable BIVA parameters also reflecting nutritional status and 
patients’ prognosis [28]. 
The reduction in QRFM thickness we observed in HD patients was statistically significant, and 
also likely to be clinically relevant (more than 20% lower as compared to the control group at each 
landmark). These results are consistent with the only other study in HD patients [17], in which a 
significant reduction of rectus femoris and vastus intermedius thickness was found in comparison to 
both young healthy adults and age-matched hospitalized patients, after adjusting for age, sex and 
BMI (p < 0.01).  
In contrast with this report [17], we did find statistical correlation only between MIS score and 
Top QRFM thickness. This finding could be explained by some limits of the MIS score: it is partially 
subjective, it includes albumin, a scarcely sensible variable for nutritional assessment, and a lower 
non-pathological cut-off value of BMI (>20 kg/m2) compared to ISRNM (>23 kg/m2) [29].  
Interesting results emerged regarding fat tissue, thigh SFT thickness was reduced in HD patients 
in comparison to controls (p < 0.001), confirming data obtained in other studies [30–32], based on 
different methods. Conversely, abdominal SFT thickness was not statistically different between the 
two groups, contradicting the result of other studies in other medical settings in which abdominal 
SFT, measured by CT, was reduced [33]. However, a partial explanation for this conflicting finding 
may reside in the fact that the ultrasonographic abdominal fat tissue thickness might be weakly 
correlated with fat mass in HD patients [34].  
Besides, analyzing the correlation between thigh and abdominal SFT thickness and nutritional 
indexes, only the abdominal SFT thickness was associated with BMI. This finding could be explained 
by the fact that BMI is not able to precisely define body composition, and underestimates both 
malnutrition and sarcopenic obesity [35]. Sharma et al. showed sarcopenic people, identified by 
DEXA, were almost all (97%) classified as non-obese by BMI [36]. 
In the second step of our analysis, we found that HD patients had lower values of BIVA 
parameters than controls, except for the two parameters that most express intra- and extracellular 
water volume, namely Rz and Rz/H. Although Rz/H is considered one of discriminant BIVA 
parameters to identify sarcopenia in elderly individuals of both sexes [37,38], our results are 
consistent with a recent study in which low accuracy of Rz/H to diagnose malnutrition in HD patients 
was demonstrated, probably because of the overhydration status of patients [27].  
A further analysis of our study showed a statistically significant correlation between QRFM 
thickness and BIVA parameters, namely PA and BCM, the BIVA surrogate parameters of muscle 
mass and that allow the identification of sarcopenia in HD patients [39,40].  
Indeed, phase angle is related to cell integrity and considered a prognostic indicator of 
nutritional risk in HD patients [41,42]. Low PA indicates muscle loss, although cut-off points to 
identify malnourished individuals are missing [43]. Similarly, body cell mass, derived from the 
calculation of total body potassium [44], is considered a valid index of skeletal muscle mass, as it 
represents the metabolic active part of cell mass.  
On the other hand, no correlations were found between thigh SFT and BIVA parameters. These 
findings could be explained by the fact that BIVA is not very accurate to evaluate the fat mass [45]. 
The strength of this study is that it reported, for the first time, the association between QRFM 
and SFT thickness evaluated by US and BIVA parameters in HD patient. The integration of US with 
BIVA, in the clinical practice, can have potential benefits since their synergy, providing an early and 
accurate identification of malnourished HD patients at bedside, might reduce the rate of morbidity 
and mortality of HD patients [46]. Although ultrasound is an easy and quick technique to visualize 
the fat and muscle mass [20,47], a dedicated education and accurate practical training are required in 
order to reduce diagnostic errors due to the operator dependent imaging modality and the lack of 
validated reference value for QRFM and SFT thickness. 
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There are, however, some limitations in our study that also should be mentioned. First, the small 
sample size of our population does not allow us to generalize our results. Further multicenter studies 
on larger samples of HD patients should be considered for future research. Another limitation is 
represented by the fact that ultrasound measurement of the subcutaneous fat was performed at four 
landmarks, less than those recently proposed [48,49] to fully evaluate the fat mass; however, this new 
evidence was not available yet when the present study was done. In addition, we did not calculate 
the body cell mass index, a more reliable index for the evaluation of body composition quality, being 
the sample too small for a correct analysis. Finally, we did not take into account the level of physical 
activity, a relevant variable of muscle mass [50–55]. However, available data strongly demonstrate 
that HD patients are prevalently sedentary [56–59] 
In conclusion, our study demonstrates that ultrasound is a valid tool to identify HD patients 
with significant reduction of quadriceps rectus femoris muscle and subcutaneous fat tissue 
thicknesses, and that muscle ultrasound measurements have good agreement with BIVA parameters. 
Ultrasound should be considered a practical, easy, and cheap tool that provides a fast analysis of 
muscle and fat mass. It could be integrated with other currently available simple techniques, such as 
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